AOI Imphal successfully treats advanced thyroid cancer cases
Source: The Sangai Express

Imphal, September 29 2024: American Oncology Institute (AOI) at Babina Specialty Hospital in Imphal has successfully treated two patients with advanced thyroid cancer, marking a major achievement in combating a condition that has been rising rapidly, especially among East Asian population and in northeast India.

Thyroid cancer is the most common malignant tumor of the endocrine (hormone) system, with approximately 570,000 cases reported annually worldwide.

This rising incidence is particularly notable among women in East Asia, where the rate has increased tenfold over the last two decades.

The northeastern region of India, sharing genetic and ethnic ties with southeast Asia, has been increasingly affected by this trend.

According to a release issued by AOI, a patient aged 43-year-old news anchor experienced hoarseness and trouble swallowing.

A CT scan revealed multiple thyroid nodules, with the largest, measuring 4 cm, pressing against his windpipe and esophagus.

The other patient, a 67-year-old woman, had severe lower back pain for two years before being diagnosed with advanced follicular thyroid cancer.

An MRI showed bone lesions from cancer spread, and a PET-CT scan detected a thyroid nodule with affected neck lymph nodes.

Both patients underwent comprehensive thyroidectomy surgeries (removal of the thyroid gland) at AOI Imphal, followed by radioactive iodine therapy.

After six months, wholebody iodine scans confirmed that both patients had achieved a complete response, with no evidence of disease.

In this regard, Dr Amit Dhawan, Regional Chief Operating Officer (RCOO) of AOI said, "Our multidisciplinary approach is what truly sets us apart.

These patients had aggressive and advanced-stage cancers, our surgical and nuclear medicine teams both achieved complete remission with combined efforts.

We are thrilled to have been able to deliver this level of care to the people of northeastern India".

Dr Dhaneshwor Naorem, Consultant Head & Neck Onco-Surgery AOI Imphal further emphasized the importance of early detection and comprehensive treatment in thyroid cancer management.

"Thyroid cancer, unlike many other forms of cancer, is often curable even at an advanced stage when managed properly.

Our ability to combine surgical expertise with radioactive iodine therapy plays a critical role in achieving successful outcomes", he added.

Harish Trivedi, CEO, AOI, echoed this sentiment, "Our commitment is to deliver world-class Cancer Care to the region, and this outcome reflects the exceptional quality of treatment provided at AOI.

While thyroid cancer rates continue to rise, so do the advancements in care that enable patients to lead healthier lives.

We are honored to serve as a source of hope for cancer patients throughout northeastern India" .

The success of these cases highlights the vital role of AOI Imphal in the region's healthcare landscape.

Both patients have now resumed their normal lives, free of disease, underscoring the importance of advanced medical care and cutting-edge treatments available at AOI Imphal.

Their successful outcomes stand as a beacon of hope for those battling thyroid cancer and other complex malignancies in the region.

Comment